Severe acute respiratory syndrome-associated coronavirus IVDs
Država: Avstralija
Jezik: angleščina
Source: Department of Health (Therapeutic Goods Administration)
Javno poročilo o oceni
(PAR)
17-01-2022
Nekateri dokumenti za ta izdelek trenutno niso na voljo, pošljete lahko zahtevo v našo stranko in obvestili vas bomo takoj, ko jih bomo lahko pridobili.
Pošlji zahtevo.
Pošlji zahtevo.
Dostopno od:
Pale Blue Medical Trading Pty Ltd
Razred:
Class 3
Izdeluje:
Jiangsu Medomics Medical Technology Co Ltd F3 Building C No 3-1 Xinjinhu Road, Jiangbei new area, Nanjing Jiangsu, 210030 China
Terapevtsko območje:
CT772 - Severe acute respiratory syndrome-associated coronavirus IVDs
Terapevtske indikacije:
Intended to detect the novel coronavirus SARS-CoV-2 that causes COVID-19 from symptomatic individuals at the point of care by trained health professionals (anterior nasal, nasopharyngeal and throat samples) and for self-testing by lay persons (nasal swab).
Status dovoljenje:
A
Datum dovoljenje:
2021-12-13
